Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
批准号:
9274850
负责人:
Daniel E. Forman
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2018-06-30
关键词:
Activities of Daily LivingAerobicAffectAgeBiologyBlood VesselsBody CompositionBreathingCardiacClinicalComplexCross-Sectional StudiesDataDiseaseDyspneaElderlyExerciseExercise TherapyFemaleFunctional disorderGene ExpressionGene Expression ProfileGenesGoalsGuidelinesHeart failureHistologyIncidenceInflammationInsulin-Like Growth Factor IIntervention TrialInvestigationLeft Ventricular Ejection FractionMeasurementMeasuresMediatingModalityMorbidity - disease rateMuscleMuscle functionMyocardial dysfunctionMyopathyOutcomePatientsPatternPerformancePerfusionPeripheralPharmaceutical PreparationsPhysiologicalPhysiologyPopulationPrevalenceProcessProteolysisQuality of lifeQuestionnairesRandomizedRegimenRelaxationResearchRespiratory DiaphragmRoentgen RaysScanningSerologicalSerumSignal TransductionSkeletal MuscleSleepSorting - Cell MovementStimulusSymptomsSystolic heart failureTherapeuticTherapeutic exerciseThinnessTrainingUbiquitinUbiquitin-mediated Proteolysis PathwayVeteransWorkadipokinesagedclinical effectcommon symptomcomparative efficacycytokineexercise capacityexercise interventionexercise intoleranceexercise regimenexercise trainingfunctional gainfunctional outcomesimprovedindexinginsightmalemode of exercisemortalitymuscle formnutritionoutcome forecastoverexpressionprognosticresponsesecondary analysisskeletalstrength training
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The population of senior Veterans prone to heart failure (HF) is expanding rapidly. Exercise intolerance and dyspnea are common symptoms that detract from independence and quality of life and also predispose to increased mortality and morbidity. Peripheral pathophysiology, particularly involving skeletal muscle (SkMx) and vascular perfusion, likely exacerbates limitations such that HF symptoms and poor outcomes relate to combined effects of central and peripheral mechanisms. While HF therapeutic guidelines emphasize cardiac therapeutic parameters, goals to modify HF SkMx function may provide vital complementary gains. This proposal focuses on benefits of exercise training for HF and evolves from a pilot analysis we began three years ago. Preliminary data show reduced functional capacity (both aerobic and strength) in older HF patients (mean age 66�10 yrs) compared to age-matched healthy controls. SkMx expression of certain genes controlling ubiquitin-mediated proteolysis in muscle correspond to the decreased aerobic and strength indices; lean muscle mass also correlates inversely to reduced strength. We now propose to compare four different exercise regimens (i.e., aerobic, strength, combined aerobic-strength, and inspiratory training) to explore how each modality changes function/symptoms in relation to specific peripheral training effects, i.e., exercise effects on SkMx biology (histology, gene expression), peripheral perfusion, and body composition. Male and female (N=200) systolic HF patients (LVEF d40%) aged e50 years will be studied. Patients will be randomized into one of four 12-week, three weekly training regimens. A comprehensive battery of functional assessments (aerobic, strength, and integrated performance), symptoms, and physiological indices (SkMx histology, gene expression, and perfusion, body composition, and serological measures of inflammation, cytokines, and adipokines) will be assessed before and after training. Specific aims are: (1) To assess differences in functional outcomes relative to the different training regimens (aerobic vs. strength vs. aerobic-strength vs. inspiratory). We hypothesize that aerobic-strength will be superior to aerobic or strength alone. We also hypothesize that inspiratory training will match the affects of traditional aerobic-strength as it imparts aerobic and strengthening physiology to the diaphragm. (2) To assess gene expression and SkMx perfusion in relation to the different training regimens. We hypothesize that proteolytic genes (FoxO, Ubiquitin) will be over-expressed in relation to diminished function and that the genes counteracting SkMx proteolysis (IGF-1, PGC-1�) will increase in relation to functional gains. Consistently, we will compare how different training regimens modulate gene expression patterns. We hypothesize that exercise modes that directly stimulate SkMx function (strength and inspiratory) will best decrease proteolytic and in- crease anabolic gene expression patterns, and exercise modes that stimulate central cardiac performance and vascular relaxation (aerobic and inspiratory training) will induce relatively greater changes in SkMx perfusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitrite Supplementation to Mitigate Fatigability and Increase Function in Long COVID Patients
-
批准号:10590380
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Daniel E. Forman
-
依托单位:
Nitrite therapy to improve mitochondrial energetics and physical activity in older adults
-
批准号:10250301
-
项目类别:
-
资助金额:$64.09万
-
财政年份:2019
-
负责人:Daniel E. Forman
-
依托单位:
Modified Application of Cardiac Rehabilitation (CR) for Older Adults (MACRO)
-
批准号:9927973
-
项目类别:
-
资助金额:$100.14万
-
财政年份:2018
-
负责人:Daniel E. Forman
-
依托单位:
Modified Application of Cardiac Rehabilitation (CR) for Older Adults (MACRO)
-
批准号:10413034
-
项目类别:
-
资助金额:$93.32万
-
财政年份:2018
-
负责人:Daniel E. Forman
-
依托单位:
Modified Application of Cardiac Rehabilitation (CR) for Older Adults (MACRO)
-
批准号:10165449
-
项目类别:
-
资助金额:$96.44万
-
财政年份:2018
-
负责人:Daniel E. Forman
-
依托单位:
Modified Application of Cardiac Rehabilitation (CR) for Older Adults (MACRO)
-
批准号:9753104
-
项目类别:
-
资助金额:$102.93万
-
财政年份:2018
-
负责人:Daniel E. Forman
-
依托单位:
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
-
批准号:8976852
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel E. Forman
-
依托单位:
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
-
批准号:8396460
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel E. Forman
-
依托单位:
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit
-
批准号:8976084
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel E. Forman
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10447586
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2004
-
负责人:Daniel E. Forman
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10668392
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2004
-
负责人:Daniel E. Forman
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10024557
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2004
-
负责人:Daniel E. Forman
-
依托单位:
Pilot/Exploratory Studies Core (PESC)
-
批准号:10221538
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2004
-
负责人:Daniel E. Forman
-
依托单位:
Pitt Integrated Clinical and Geroscience Research Training Program
-
批准号:10627975
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2003
-
负责人:Daniel E. Forman
-
依托单位:
ACTION - A CHF Trial Investigating Outcomes of Exercise
-
批准号:6424457
-
项目类别:
-
资助金额:$18.05万
-
财政年份:2002
-
负责人:Daniel E. Forman
-
依托单位:
ACTION - A CHF Trial Investigating Outcomes of Exercise
-
批准号:6668530
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2002
-
负责人:Daniel E. Forman
-
依托单位:
海外基金